Plain-English translation of NCT06615466 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to radiation therapy called super-hypofractionated partial breast irradiation. Instead of targeting the entire breast over several weeks, this treatment focuses radiation beams directly on the area where the tumor was removed, completing the treatment in just one week. This is designed for women with early-stage, low-risk breast cancer who have had breast-conserving surgery.
Many women with early breast cancer receive radiation after surgery, but the standard treatment takes 3–6 weeks and can cause side effects. This trial is exploring whether giving focused radiation in a shorter time — just one week — can work just as well while reducing discomfort and inconvenience for patients.
You likely qualify if…
You likely don't qualify if…
You would receive radiation treatment five times over one week (once per day), with each session lasting about 15–20 minutes. Before treatment starts, your doctors will place a small metal marker at the tumor site to help guide the radiation beams precisely. You will be monitored closely during and after treatment to check for any side effects, with follow-up visits to track how well the treatment worked and how you're recovering.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
China